©The Author(s) 2015.
World J Neurol. Sep 28, 2015; 5(3): 88-101
Published online Sep 28, 2015. doi: 10.5316/wjn.v5.i3.88
Published online Sep 28, 2015. doi: 10.5316/wjn.v5.i3.88
Table 1 World Health Organization classification of gliomas
| Localized astrocytoma |
| WHO grade I |
| Pilocytic astrocytoma |
| Pleomorphic xanthoastrocytoma |
| Subependymal giant cell astrocytoma |
| Diffuse astrocytomas/oligodendrogliomas |
| WHO grade II (Astrocytoma) |
| Fibrillary |
| Protoplasmic |
| Gemistocytic |
| WHO grade II (Oligodendroglioma) |
| WHO grade III (Anaplastic astrocytoma) |
| WHO grade III (Anaplastic oligodendroglioma) |
| WHO grade IV (Glioblastoma multiforme) |
| Giant cell glioblastoma |
| Gliosarcoma |
- Citation: Joshi SK, Lucic N, Zuniga R. Molecular pathogenesis of glioblastoma multiforme: Nuances, obstacles, and implications for treatment. World J Neurol 2015; 5(3): 88-101
- URL: https://www.wjgnet.com/2218-6212/full/v5/i3/88.htm
- DOI: https://dx.doi.org/10.5316/wjn.v5.i3.88